Ultra-portable X-ray developer secures $24M BARDA contract

Oxos Medical has been awarded a BARDA contract worth up to $24.4M to develop and seek FDA clearance for its next-gen ultra-portable X-ray system, Oxos X3, aiming for point-of-care and mass-casualty triage.

• The contract covers the full lifecycle from development and validation through manufacturing transfer and human-factor studies, culminating in an FDA submission.
• Oxos already markets a handheld FDA-cleared digital radiographic system used by orthopedic providers, urgent care clinics, NFL teams, and medical educators.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.